Ashwini Samel

Title: Innovations by Ashwini Samel in Pharmaceutical Compositions

Introduction

Ashwini Samel is an accomplished inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on controlled release formulations. With a total of 2 patents to his name, his work is paving the way for advancements in medication delivery systems.

Latest Patents

Ashwini Samel's latest patents include two innovative pharmaceutical compositions. The first patent is titled "pH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol." This invention relates to a controlled release pharmaceutical composition that includes a core with at least one opioid active ingredient. The core is coated with a polymer mixture that controls the release of the composition, ensuring efficacy while minimizing the influence of ethanol.

The second patent is titled "pH-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol." This invention also features a controlled release composition, but it focuses on pharmaceutical active ingredients other than opioids. Similar to the first patent, it utilizes a polymer mixture for the coating layer, which is designed to control the release of the active ingredients effectively.

Career Highlights

Ashwini Samel is currently employed at Evonik Roehm GmbH, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug formulations and enhancing patient outcomes through advanced technology.

Collaborations

Throughout his career, Ashwini has collaborated with notable colleagues, including Hans-Ulrich Petereit and Hema Ravishankar. These collaborations have contributed to the development of his innovative patents and have fostered a productive research environment.

Conclusion

Ashwini Samel's contributions to pharmaceutical innovations demonstrate his expertise and dedication to improving medication delivery systems. His patents reflect a significant advancement in controlled release formulations, which can greatly benefit patients in the future.